Multicenter Analysis of Impact of High Biologically Effective Dose (BED) on Biochemical Failure (Phoenix Definition) and Survival Outcomes in Patients With Gleason Score 7–10 Prost... von Stone, N.N, Potters, L, Davis, B.J, Ciezki, J, Zelefsky, M, Roach, M, Fearn, P.A, Kattan, M, Stock, R.G

Volltext

104 von Kattan, M.W., Stock, R.G., Ciezki, J.P., Davis, B.J., Zelefsky, M.J., Roach, M., Stone, N.N., Fearn, P.A., Potters, L.

Volltext

20 von Stone, N.N., Potters, L., Davis, B.J., Ciezki, J.P., Zelefsky, M.J., Roach, M., Fearn, P.A., Kattan, M.W., Stock, R.G.

Volltext

2214 von Potters, L., Stock, R.G., Ciezki, J.P., Davis, B.J., Zelefsky, M.J., Roach, M., Stone, N.N., Fearn, P.A., Kattan, M.W.

Volltext

104: An Updated 9-Year Preoperative Nomogram Predicting for Prostate Cancer Recurrence After Permanent Prostate Brachytherapy von Kattan, M.W., Stock, R.G., Ciezki, J.P., Davis, B.J., Zelefsky, M.J., Roach, M., Stone, N.N., Fearn, P.A., Potters, L.

Volltext

20: Customized Dose Prescription for Prostate Brachytherapy: Insights From a Multicenter Analysis of Dosimetry Outcomes von Stone, N.N., Potters, L., Davis, B.J., Ciezki, J.P., Zelefsky, M.J., Roach, M., Fearn, P.A., Kattan, M.W., Stock, R.G.

Volltext

2214: Postoperative Nomogram Predicting the 9-Year Probability of Prostate Cancer Recurrence After Permanent Prostate Brachytherapy von Potters, L., Stock, R.G., Ciezki, J.P., Davis, B.J., Zelefsky, M.J., Roach, M., Stone, N.N., Fearn, P.A., Kattan, M.W.

Volltext